StockData
Solid Biosciences Inc. logo

Solid Biosciences Inc. (SLDB) stock

SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$6.23−0.25 (-3.86%)

Close on Nov 17, 2026Market cap $668.01MP/E –Yield –

Solid Biosciences cash

Cash and short-term investments held at the end of each period.

Solid Biosciences's cash was $377.70M at Jun 30, 2026. For fiscal 2025 it was $187.90M, up 26.2% from the year before. Over ten years it grew 20.7% a year on average. The highest annual figure on record is $213.72M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$187.90M+26.2%
FY2024Dec 31, 2024$148.90M+20.4%
FY2023Dec 31, 2023$123.64M-42.1%
FY2022Dec 31, 2022$213.72M+2.9%
FY2021Dec 31, 2021$207.78M+34.0%
FY2020Dec 31, 2020$155.07M+85.7%
FY2019Dec 31, 2019$83.52M-31.8%
FY2018Dec 31, 2018$122.46M+77.1%
FY2017Dec 31, 2017$69.16M+781.8%
FY2016Dec 31, 2016$7.84M-72.6%
FY2015Dec 31, 2015$28.60M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$377.70M+40.9%
Q1 FY2026Mar 31, 2026$380.70M+24.0%
Q4 FY2025Dec 31, 2025$187.90M+26.2%
Q3 FY2025Sep 30, 2025$236.10M+38.0%
Q2 FY2025Jun 30, 2025$268.10M+40.9%
Q1 FY2025Mar 31, 2025$306.90M+48.9%
Q4 FY2024Dec 31, 2024$148.90M+20.4%
Q3 FY2024Sep 30, 2024$171.10M+19.7%
Q2 FY2024Jun 30, 2024$190.30M+18.8%
Q1 FY2024Mar 31, 2024$206.10M+11.1%
Q4 FY2023Dec 31, 2023$123.64M-42.1%
Q3 FY2023Sep 30, 2023$142.88M+0.5%
Q2 FY2023Jun 30, 2023$160.19M-1.7%
Q1 FY2023Mar 31, 2023$185.51M+3.0%
Q4 FY2022Dec 31, 2022$213.72M+2.9%
Q3 FY2022Sep 30, 2022$142.16M-38.1%
Q2 FY2022Jun 30, 2022$162.88M-34.6%
Q1 FY2022Mar 31, 2022$180.05M-32.9%
Q4 FY2021Dec 31, 2021$207.78M+34.0%
Q3 FY2021Sep 30, 2021$229.76M+826.6%
Q2 FY2021Jun 30, 2021$248.96M+510.7%
Q1 FY2021Mar 31, 2021$268.50M+401.0%
Q4 FY2020Dec 31, 2020$155.07M+85.7%
Q3 FY2020Sep 30, 2020$24.80M-76.5%
Q2 FY2020Jun 30, 2020$40.77M-39.5%
Q1 FY2020Mar 31, 2020$53.59M-43.4%
Q4 FY2019Dec 31, 2019$83.52M-31.8%
Q3 FY2019Sep 30, 2019$105.66M-27.3%
Q2 FY2019Jun 30, 2019$67.39M-58.6%
Q1 FY2019Mar 31, 2019$94.74M-48.1%
Q4 FY2018Dec 31, 2018$122.46M+77.1%
Q3 FY2018Sep 30, 2018$145.37M+868.0%
Q2 FY2018Jun 30, 2018$162.76M+397.5%
Q1 FY2018Mar 31, 2018$182.38M+523.2%
Q4 FY2017Dec 31, 2017$69.16M+781.8%
Q3 FY2017Sep 30, 2017$15.02M-47.5%
Q2 FY2017Jun 30, 2017$32.72M–
Q1 FY2017Mar 31, 2017$29.27M–
Q4 FY2016Dec 31, 2016$7.84M–
Q4 FY2015Dec 31, 2015$28.60M–

More Solid Biosciences figures

See a number that looks wrong?